Back to All Events
ESMO Congress is one of the world’s leading oncology meetings. CHOSA presented the poster/abstract “Validation of a cisplatin response predictor in carboplatin-treated metastatic breast cancer patients,” highlighting our continued work in precision oncology.
Previous
Previous
October 13
Nordic Life Science Days
Next
Next
November 3